References
- Bray GA. Greenway FL. Pharmacological approaches to treating the obese patient. Clin Endocrinol Metab 1976: 5(2): 455–79
- Mayer J. Overweight: causes, costs, and control. New York: Prentice-Hall. 1968
- DeLuise M, Blackbnrn GL, Flier JS. Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med 1980: 303: 1017–22
- Bray GA, Kral JG, Björntorp P. Hepatic sodiumpotassium-dependent ATPase in obesity. N Engl J Med 1981: 304: 1580–2
- Mir MA, Charalambous BM, Morgan K, et al. Erythrocyte sodlum-potassium-ATPase and sodium transport in obesity. N Engl J Med 1981: 305: 1264–8
- Newmholme EA. A possible metabolic basis for the control of body weight. N Engl J Med 1980: 302: 400–5
- Andres R. Effect of obesity on total mortality. Int J Obes 1980: 4: 381–6
- Drenick EJ, Bale GS, Seltzer P, et al. Excessive mortality and causes of death In morbidly obese men. JAMA 1980: 243: 443–5
- Stunkard A, McLaren-Hume M. The results of treatment for obesity: a review of the literature and report of a series. Arch Intern Med 1959: 103: 79–85
- Bistrian BR. Clinical use of a protein-sparing modified fast. JAMA 1978: 240: 2299–302
- Straw WE. The treatment of resistant obesity. Female Patient 1981 Jan: 6: 55–65
- Albrink MJ. Chorionic gonadotropin and obesity? Am J Clin Nutr 1969: 22-681-5
- Young RL. Pudu RJ. Woltjen MJ. Chorionic gonadotropin in weight control: a double-blind crossover study. JAMA 1976: 236: 2495–7
- Mann GV. The influence of obesity on health. 2. N Engl J Med 1974: 291: 226–32
- Alden JF. Gastric and jejunoileal bypass: a comparison in the treatment of morbid obesity. Arch Surg 1979: 112: 799–806